Addressing unmet medical needs in relapsing-remitting multiple sclerosis:
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
London
Future Medicine Ltd
c2011
|
| Schriftenreihe: | Future Science Group eBook collection
|
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Beschreibung: | Includes bibliographical references and index Addressing unmet medical needs in RR-MS / Robert A. Bermel & Richard A. Rudick -- Current guidelines and standard treatments of RR-MS / R. Philip Kinkel & Augusto Miravalle -- Oral agents for the treatment of RR-MS / Douglas R. Jeffery -- Monoclonal antibodies / Jennifer Graves & Emmanuelle L. Waubant -- Other therapeutics in the pipeline and future directions / Yuval Karmon, Bijal K. Mehta & Bianca Weinstock-Guttman |
| Beschreibung: | 1 electronic text (77 p.) |
| ISBN: | 9781780840208 9781780840215 9781780840246 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV039836743 | ||
| 003 | DE-604 | ||
| 005 | 20120312 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 120124s2011 |||| o||u| ||||||eng d | ||
| 020 | |a 9781780840208 |9 978-1-78084-020-8 | ||
| 020 | |a 9781780840215 |9 978-1-78084-021-5 | ||
| 020 | |a 9781780840246 |c eBook |9 978-1-78084-024-6 | ||
| 024 | 7 | |a 10.2217/9781780840246 |2 doi | |
| 035 | |a (OCoLC)768375622 | ||
| 035 | |a (DE-599)BVBBV039836743 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.8/3406 |2 22 | |
| 084 | |a YG 6015 |0 (DE-625)153507:12921 |2 rvk | ||
| 245 | 1 | 0 | |a Addressing unmet medical needs in relapsing-remitting multiple sclerosis |c editors Richard A. Rudick ... |
| 264 | 1 | |a London |b Future Medicine Ltd |c c2011 | |
| 300 | |a 1 electronic text (77 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Future Science Group eBook collection | |
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a Addressing unmet medical needs in RR-MS / Robert A. Bermel & Richard A. Rudick -- Current guidelines and standard treatments of RR-MS / R. Philip Kinkel & Augusto Miravalle -- Oral agents for the treatment of RR-MS / Douglas R. Jeffery -- Monoclonal antibodies / Jennifer Graves & Emmanuelle L. Waubant -- Other therapeutics in the pipeline and future directions / Yuval Karmon, Bijal K. Mehta & Bianca Weinstock-Guttman | ||
| 650 | 4 | |a Multiple sclerosis / Treatment | |
| 650 | 4 | |a Interferon / Therapeutic use | |
| 650 | 4 | |a Peptides / Therapeutic use | |
| 650 | 4 | |a Monoclonal antibodies / Therapeutic use | |
| 650 | 4 | |a Antineoplastic agents / Therapeutic use | |
| 650 | 0 | 7 | |a Multiple Sklerose |0 (DE-588)4040693-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
| 653 | |a Electronic books | ||
| 689 | 0 | 0 | |a Multiple Sklerose |0 (DE-588)4040693-3 |D s |
| 689 | 0 | 1 | |a Therapie |0 (DE-588)4059798-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Rudick, Richard A. |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://www.futuremedicine.com/doi/book/10.2217/9781780840246 |x Verlag |3 Volltext |
| 912 | |a ZDB-81-FSG | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-024696726 | ||
| 966 | e | |u http://www.futuremedicine.com/doi/book/10.2217/9781780840246 |l UBR01 |p ZDB-81-FSG |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804148767003246592 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV039836743 |
| classification_rvk | YG 6015 |
| collection | ZDB-81-FSG |
| ctrlnum | (OCoLC)768375622 (DE-599)BVBBV039836743 |
| dewey-full | 616.8/3406 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.8/3406 |
| dewey-search | 616.8/3406 |
| dewey-sort | 3616.8 43406 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02335nmm a2200517zc 4500</leader><controlfield tag="001">BV039836743</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20120312 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">120124s2011 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781780840208</subfield><subfield code="9">978-1-78084-020-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781780840215</subfield><subfield code="9">978-1-78084-021-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781780840246</subfield><subfield code="c">eBook</subfield><subfield code="9">978-1-78084-024-6</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2217/9781780840246</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)768375622</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV039836743</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.8/3406</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YG 6015</subfield><subfield code="0">(DE-625)153507:12921</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Addressing unmet medical needs in relapsing-remitting multiple sclerosis</subfield><subfield code="c">editors Richard A. Rudick ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London</subfield><subfield code="b">Future Medicine Ltd</subfield><subfield code="c">c2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic text (77 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Future Science Group eBook collection</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Addressing unmet medical needs in RR-MS / Robert A. Bermel & Richard A. Rudick -- Current guidelines and standard treatments of RR-MS / R. Philip Kinkel & Augusto Miravalle -- Oral agents for the treatment of RR-MS / Douglas R. Jeffery -- Monoclonal antibodies / Jennifer Graves & Emmanuelle L. Waubant -- Other therapeutics in the pipeline and future directions / Yuval Karmon, Bijal K. Mehta & Bianca Weinstock-Guttman</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Multiple sclerosis / Treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Interferon / Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Peptides / Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Monoclonal antibodies / Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic agents / Therapeutic use</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Multiple Sklerose</subfield><subfield code="0">(DE-588)4040693-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Electronic books</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Multiple Sklerose</subfield><subfield code="0">(DE-588)4040693-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rudick, Richard A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.futuremedicine.com/doi/book/10.2217/9781780840246</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-81-FSG</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-024696726</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://www.futuremedicine.com/doi/book/10.2217/9781780840246</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-81-FSG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV039836743 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T00:12:22Z |
| institution | BVB |
| isbn | 9781780840208 9781780840215 9781780840246 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-024696726 |
| oclc_num | 768375622 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 electronic text (77 p.) |
| psigel | ZDB-81-FSG |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | Future Medicine Ltd |
| record_format | marc |
| series2 | Future Science Group eBook collection |
| spelling | Addressing unmet medical needs in relapsing-remitting multiple sclerosis editors Richard A. Rudick ... London Future Medicine Ltd c2011 1 electronic text (77 p.) txt rdacontent c rdamedia cr rdacarrier Future Science Group eBook collection Includes bibliographical references and index Addressing unmet medical needs in RR-MS / Robert A. Bermel & Richard A. Rudick -- Current guidelines and standard treatments of RR-MS / R. Philip Kinkel & Augusto Miravalle -- Oral agents for the treatment of RR-MS / Douglas R. Jeffery -- Monoclonal antibodies / Jennifer Graves & Emmanuelle L. Waubant -- Other therapeutics in the pipeline and future directions / Yuval Karmon, Bijal K. Mehta & Bianca Weinstock-Guttman Multiple sclerosis / Treatment Interferon / Therapeutic use Peptides / Therapeutic use Monoclonal antibodies / Therapeutic use Antineoplastic agents / Therapeutic use Multiple Sklerose (DE-588)4040693-3 gnd rswk-swf Therapie (DE-588)4059798-2 gnd rswk-swf Electronic books Multiple Sklerose (DE-588)4040693-3 s Therapie (DE-588)4059798-2 s DE-604 Rudick, Richard A. Sonstige oth http://www.futuremedicine.com/doi/book/10.2217/9781780840246 Verlag Volltext |
| spellingShingle | Addressing unmet medical needs in relapsing-remitting multiple sclerosis Multiple sclerosis / Treatment Interferon / Therapeutic use Peptides / Therapeutic use Monoclonal antibodies / Therapeutic use Antineoplastic agents / Therapeutic use Multiple Sklerose (DE-588)4040693-3 gnd Therapie (DE-588)4059798-2 gnd |
| subject_GND | (DE-588)4040693-3 (DE-588)4059798-2 |
| title | Addressing unmet medical needs in relapsing-remitting multiple sclerosis |
| title_auth | Addressing unmet medical needs in relapsing-remitting multiple sclerosis |
| title_exact_search | Addressing unmet medical needs in relapsing-remitting multiple sclerosis |
| title_full | Addressing unmet medical needs in relapsing-remitting multiple sclerosis editors Richard A. Rudick ... |
| title_fullStr | Addressing unmet medical needs in relapsing-remitting multiple sclerosis editors Richard A. Rudick ... |
| title_full_unstemmed | Addressing unmet medical needs in relapsing-remitting multiple sclerosis editors Richard A. Rudick ... |
| title_short | Addressing unmet medical needs in relapsing-remitting multiple sclerosis |
| title_sort | addressing unmet medical needs in relapsing remitting multiple sclerosis |
| topic | Multiple sclerosis / Treatment Interferon / Therapeutic use Peptides / Therapeutic use Monoclonal antibodies / Therapeutic use Antineoplastic agents / Therapeutic use Multiple Sklerose (DE-588)4040693-3 gnd Therapie (DE-588)4059798-2 gnd |
| topic_facet | Multiple sclerosis / Treatment Interferon / Therapeutic use Peptides / Therapeutic use Monoclonal antibodies / Therapeutic use Antineoplastic agents / Therapeutic use Multiple Sklerose Therapie |
| url | http://www.futuremedicine.com/doi/book/10.2217/9781780840246 |
| work_keys_str_mv | AT rudickricharda addressingunmetmedicalneedsinrelapsingremittingmultiplesclerosis |